University of California San Francisco
Give to UCSFJanel Long-Boyle, a faculty member in the UCSF School of Pharmacy's Department of Clinical Pharmacy, has spent her career advancing lifesaving drugs.
UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities.
UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this
Image courtesy of the National Cancer Institute Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would
More than 150 people have signed up to shave their heads at UCSF Benioff Children’s Hospital Oakland on March 16, to support the 12th annual Brave the Shave fundraiser for pediatric cancer research.
Chemtai Mungo, MD, MPH, is committed to tackling the public health effects of gender inequality and helping to improve cervical cancer screening in Kenya.
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UCSF has found.
UCSF's Thea Tlsty is a winner of the “Grand Challenge” competition sponsored by Cancer Research UK. Her international team will receive $26 million to uncover how chronic inflammation causes cancer.
In laboratory experiments, UCSF researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach.
The amount of radiation that patients are exposed to from CT scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines.
Cynthia Perlis shares her top learnings from 30 years of listening to cancer patients at UCSF.
Study, led by UCSF, raises intriguing questions about whether the biology of low-risk prostate cancer in black men is distinct from that of other ethnicities.
From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.
Anxiety and depression may be leading predictors of conditions ranging from heart disease to headaches, having similar effects as long-established risk factors like smoking and obesity.
UCSF scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.
A UCSF surgeon is among a handful nationwide who are pioneering and studying the outcomes of a new approach to breast reconstruction.